908 Devices (MASS) Depreciation & Amortization (CF) (2020 - 2026)
908 Devices' (MASS) quarterly Depreciation & Amortization (CF) came in at $1.1 million in Q1 2026, down 11.77% year-on-year from $1.3 million in Q1 2025, and up 2.52% on a QoQ basis from $1.1 million in Q4 2025.
908 Devices (MASS) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 million in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 11.77% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 7.15% decrease from a year earlier, with the FY2025 full-year figure at $4.5 million, down 4.63% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $1.1 million, up from $1.1 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for MASS reached as high as $1.4 million in Q4 2024 and fell as low as $267000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $840235.3 across 5 years, with a median of $740000.0 in 2023.
- Across the five-year window, Depreciation & Amortization (CF) declined 29.81% in 2023 and jumped 254.81% in 2024, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $577000.0 in 2022, then declined by 29.81% to $405000.0 in 2023, then soared by 254.81% to $1.4 million in 2024, then retreated by 22.69% to $1.1 million in 2025, then grew by 2.52% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 67.10 Mn |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 310.25 Mn |
| 10 | 908 Devices | 259.57 Mn | 147.83 Mn | 6.88 Mn | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 972,000.00 |
| Jun 30, 2025 | 972,000.00 |
| Mar 31, 2025 | 1.29 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 504,000.00 |
| Jun 30, 2024 | 504,000.00 |
| Mar 31, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 405,000.00 |
| Dec 31, 2023 | 405,000.00 |